In cases of non-small cell lung cancer, pairing medlinkimmunotherapy/medlink with dupilumab- frequently used to treat allergies and medlinkasthma/medlink improved patients' immune systems and demonstrated a notable reduction in tumor size. Dupilumab is an antibody that blocks the allergic pathway Interleukin-4 (IL-4) receptor and exhibited anti-tumor response.
The findings were described in the December 6 issue of iNature/i (!--ref1--).
h2 Unveiling Molecular Strategies ...
In cases of non-small cell lung cancer, pairing medlinkimmunotherapy/medlink with dupilumab- frequently used to treat allergies and medlinkasthma/medlink improved patients' immune systems and demonstrated a notable reduction in tumor size. Dupilumab is an antibody that blocks the allergic pathway Interleukin-4 (IL-4) receptor and exhibited anti-tumor response.
The findings were described in the December 6 issue of iNature/i (!--ref1--).
h2 Unveiling Molecular Strategies ...